MET-PE — MetLife, Inc.

Summary of MetLife's Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 Adjusted Earnings: $1.6 billion or $2.49 per share; $2.58 per share excluding notable items (up 24% YoY).
• Full Year Adjusted Earnings: $6 billion or $8.89 per share, reflecting a 10% increase YoY.
• Adjusted Return on Equity (ROE): 16%, within the target range of 15%-17%.
• Direct Expense Ratio: Improved to 11.7%, ahead of the 12.1% target for 2026.
• Free Cash Flow: $4.9 billion generated in 2025, contributing to a five-year target of $25 billion.
• Net Income: Approximately $800 million for Q4 and $3.2 billion for the full year.

2. Strategic Updates and Business Highlights:

• MetLife's strategic initiative, New Frontier, focuses on growth, capital deployment, and operational efficiency.
• The Group Benefits segment added ~$100 million in adjusted premiums, with voluntary PFOs up 10% YoY.
• Record Pension Risk Transfer (PRT) sales exceeded $14 billion, marking the highest annual total.
• Acquisition of PineBridge Investments established a new segment, MetLife Investment Management (MIM), which ended the year with $742 billion in assets under management.
• Strong performance in international markets: Asia sales grew 18% and Latin America 12% in constant currency.

3. Forward Guidance and Outlook:

• 2026 Expectations:
  • Double-digit adjusted EPS growth.
  • Adjusted ROE to remain in the 15%-17% range.
  • Free cash flow ratio target of 65%-75% of adjusted earnings.
  • Group Benefits adjusted earnings growth projected at 7%-9%.
  • Retirement and Income Solutions (RIS) earnings expected between $1.6 billion and $1.8 billion.
  • MIM adjusted earnings forecasted between $240 million and $280 million.

4. Bad News, Challenges, or Points of Concern:

• Disability Experience: Weaker than expected results due to higher average severity and incidents, although overall trends remain stable.
• Surrender Activity: Increased in Q4 due to currency fluctuations, with expectations of returning to long-term assumptions in 2026.
• Variable Investment Income (VII): Fell short of the $1.7 billion target for 2025, primarily due to lower real estate returns.
• Regulatory Changes: Potential impacts from mandatory paid family leave programs in various states, which may affect growth dynamics.

5. Notable Q&A Insights:

• Group Benefits: Persistency and renewal results are robust, with dental pricing adjustments yielding positive outcomes.
• Japan Market: Macro volatility has led to increased surrenders, but overall sales remain strong; MetLife maintains a competitive position.
• AI Impact: While AI-driven employment changes are acknowledged, MetLife's diversified book and strong sales growth mitigate potential negative impacts.
• MIM and Brighthouse Relationship: The acquisition of Brighthouse by Aquarion may have modest impacts on MetLife's earnings, but the overall diversified client base provides stability.

Overall, MetLife demonstrated strong financial performance in 2025, achieving significant growth across various segments while navigating challenges in the market. The company remains optimistic about its strategic direction and future growth potential.